Locoregional Therapies for Hepatocellular Carcinoma What Has Changed in the Past Ten Years?

The evolution of LRT in the last decade has allowed for broader patient selection, individualized therapy with a refined, targeted approach and less systemic toxicity, and improved patient outcomes. With the rapidly changing landscape of systemic therapy, the role of LRT alone or in combination for downstaging and curative intent will continue to evolve as we await this coming decade.